{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:52Z","timestamp":1792785052028,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"King Fahad Medical City","award":["022-006"],"award-info":[{"award-number":["022-006"]}],"id":[{"id":"https:\/\/ror.org\/03xhv9997","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60696-3","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:45:13Z","timestamp":1783111513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An epitope-based peptide vaccine targeting influenza a elicits robust immune responses and induces protection in a mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"Bandar","family":"Alosaimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halah Z.","family":"Al-Rawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia T.","family":"Al-Shouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roua","family":"Alsubki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaweya E.","family":"Awadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"60696_CR1","doi-asserted-by":"publisher","unstructured":"Wang, W. C., Sayedahmed, E. E., Sambhara, S. & Mittal, S. K. Progress towards the development of a universal influenza vaccine, Viruses, vol. 14, no. 8, Jul 30 https:\/\/doi.org\/10.3390\/v14081684 (2022).","DOI":"10.3390\/v14081684"},{"key":"60696_CR2","doi-asserted-by":"crossref","unstructured":"Rockman, S. & Laurie, K. Understanding the implications of delaying seasonal influenza vaccine recommendations: An Industry Perspective, Vaccines, vol. 13, no. 9, p. 89110.3390\/vaccines13090891","DOI":"10.3390\/vaccines13090891"},{"key":"60696_CR3","doi-asserted-by":"publisher","unstructured":"Taaffe, J. et al. Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact, Vaccine, vol. 42, no. 26, p. 126408, 2024\/12\/02\/ https:\/\/doi.org\/10.1016\/j.vaccine.2024.126408 (2024).","DOI":"10.1016\/j.vaccine.2024.126408"},{"key":"60696_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/v15010116","author":"J Li","year":"2022","unstructured":"Li, J., Zhang, Y., Zhang, X. & Liu, L. Influenza and universal vaccine research in China. Viruses https:\/\/doi.org\/10.3390\/v15010116 (2022).","journal-title":"Viruses"},{"key":"60696_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711997","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen, J., Wang, J., Zhang, J. & Ly, H. Advances in development and application of influenza vaccines. Front. Immunol. 12, 711997. https:\/\/doi.org\/10.3389\/fimmu.2021.711997 (2021).","journal-title":"Front. Immunol."},{"key":"60696_CR6","doi-asserted-by":"publisher","unstructured":"Li, M. et al. Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses, Animal Diseases, vol. 5, no. 1, p. 33, 2025\/08\/21 https:\/\/doi.org\/10.1186\/s44149-025-00187-6 (2025).","DOI":"10.1186\/s44149-025-00187-6"},{"key":"60696_CR7","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Advances in protein subunit vaccines against H1N1\/09 influenza, Frontiers in Immunology, Review vol. Volume 15\u20132024, 2024-November-22 2024, (2024). https:\/\/doi.org\/10.3389\/fimmu. 1499754.","DOI":"10.3389\/fimmu"},{"issue":"12","key":"60696_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a038604","volume":"10","author":"R Honce","year":"2020","unstructured":"Honce, R., Wohlgemuth, N., Meliopoulos, V. A., Short, K. R. & Schultz-Cherry, S. Influenza in High-Risk Hosts-Lessons Learned from Animal Models. Cold Spring Harb Perspect. Med. 10 (12), 1. https:\/\/doi.org\/10.1101\/cshperspect.a038604 (2020).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"60696_CR9","doi-asserted-by":"publisher","unstructured":"Haas, K. M. et al. Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. Nat. Commun. 14 (1), 6030. https:\/\/doi.org\/10.1038\/s41467-023-41442-z (2023).","DOI":"10.1038\/s41467-023-41442-z"},{"issue":"1","key":"60696_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36120-z","volume":"14","author":"HM Ollila","year":"2023","unstructured":"Ollila, H. M. et al. Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy. Nat. Commun. 14(1), 2709. https:\/\/doi.org\/10.1038\/s41467-023-36120-z (2023).","journal-title":"Nat. Commun."},{"key":"60696_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.902840","volume":"13","author":"SM Buonocore","year":"2022","unstructured":"Buonocore, S. M. & van der Most, R. G. Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?. Front. Immunol. 13, 902840. https:\/\/doi.org\/10.3389\/fimmu.2022.902840 (2022).","journal-title":"Front. Immunol."},{"key":"60696_CR12","doi-asserted-by":"publisher","unstructured":"Grohskopf, L. A., Ferdinands, J. M., Blanton, L. H., Broder, K. R. & Loehr, J. Prevention and Control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. MMWR Recomm Rep, 73, 5, pp. 1\u201325, Aug 29 https:\/\/doi.org\/10.15585\/mmwr.rr7305a1 (2024).","DOI":"10.15585\/mmwr.rr7305a1"},{"key":"60696_CR13","doi-asserted-by":"publisher","unstructured":"Sharifi, E. et al. Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants. J. Nanobiotechnol. 21 (1), 199. https:\/\/doi.org\/10.1186\/s12951-023-01938-8 (Jun 21 2023).","DOI":"10.1186\/s12951-023-01938-8"},{"key":"60696_CR14","doi-asserted-by":"publisher","unstructured":"Awadalla, M. E. et al. Moderately low effectiveness of the influenza quadrivalent vaccine: potential mismatch between circulating strains and vaccine strains. Vaccines (Basel). 11 (6). https:\/\/doi.org\/10.3390\/vaccines11061050 (2023).","DOI":"10.3390\/vaccines11061050"},{"key":"60696_CR15","doi-asserted-by":"publisher","unstructured":"An, Y. et al. High-throughput pseudovirus neutralisation maps the antigenic landscape of influenza A\/H1N1 viruses, eBioMedicine, 122, (2025). https:\/\/doi.org\/10.1016\/j.ebiom.2025.106047","DOI":"10.1016\/j.ebiom.2025.106047"},{"issue":"3","key":"60696_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00867-24","volume":"99","author":"H Park","year":"2025","unstructured":"Park, H. et al. Diversifying T-cell responses: Safeguarding against pandemic influenza with mosaic nucleoprotein. J. Virol. 99(3), e0086724. https:\/\/doi.org\/10.1128\/jvi.00867-24 (2025).","journal-title":"J. Virol."},{"issue":"Suppl_1","key":"60696_CR17","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","volume":"219","author":"F Krammer","year":"2019","unstructured":"Krammer, F. & Palese, P. Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain. J. Infect. Dis. 219(Suppl_1), S62-s67. https:\/\/doi.org\/10.1093\/infdis\/jiy711 (2019).","journal-title":"J. Infect. Dis."},{"key":"60696_CR18","doi-asserted-by":"publisher","unstructured":"Sautto, G. A., Kirchenbaum, G. A. & Ross, T. M. Towards a universal influenza vaccine: different approaches for one goal. Virology Journal, 15, 1, p. 17, 2018\/01\/19 2018, https:\/\/doi.org\/10.1186\/s12985-017-0918-y","DOI":"10.1186\/s12985-017-0918-y"},{"key":"60696_CR19","doi-asserted-by":"publisher","unstructured":"Jang, Y. H. & Seong, B. L. The Quest for a Truly Universal Influenza Vaccine, Frontiers in Cellular and Infection Microbiology, Review vol. Volume 9\u2013 2019-October-10 2019, (2019). https:\/\/doi.org\/10.3389\/fcimb.2019.00344","DOI":"10.3389\/fcimb.2019.00344"},{"key":"60696_CR20","doi-asserted-by":"publisher","unstructured":"Carlock, M. A. & Ross, T. M. A computationally optimized broadly reactive hemagglutinin vaccine elicits neutralizing antibodies against influenza B viruses from both lineages, Scientific Reports, vol. 13, no. 1, p. 15911, 2023\/09\/23 2023. https:\/\/doi.org\/10.1038\/s41598-023-43003-2","DOI":"10.1038\/s41598-023-43003-2"},{"key":"60696_CR21","doi-asserted-by":"crossref","unstructured":"[21], P. L., Sanchez, A., Lynch & Ross, T. M. Multivalent COBRA hemagglutinin and neuraminidase influenza vaccines adjuvanted with TLR9 agonist CpG 1018, Vaccines, vol. 13, no. 7, p. 662, [Online]. Available: https:\/\/www.mdpi.com\/2076-393X\/13\/7\/662 (2025).","DOI":"10.3390\/vaccines13070662"},{"key":"60696_CR22","doi-asserted-by":"publisher","unstructured":"Zuckermann, F. A. et al. An effective vaccine against influenza A virus based on the matrix protein 2 (M2), Veterinary Microbiology, 298, p. 110245, 2024\/11\/01\/ 2024, doi: https:\/\/doi.org\/10.1016\/j.vetmic.2024.110245","DOI":"10.1016\/j.vetmic.2024.110245"},{"key":"60696_CR23","doi-asserted-by":"publisher","unstructured":"Olukitibi, T. A. et al. Development and characterization of influenza M2 ectodomain and\/or hemagglutinin stalk-based dendritic cell-targeting vaccines, Frontiers in Microbiology, Original Research vol. Volume 13\u20132022, 2022-August-08 2022, (2022). https:\/\/doi.org\/10.3389\/fmicb. 937192.","DOI":"10.3389\/fmicb"},{"key":"60696_CR24","doi-asserted-by":"crossref","unstructured":"Gomes, K. B. et al. Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery, Viruses, vol. 14, no. 9, p. 2022. [Online]. (1920). Available: https:\/\/www.mdpi.com\/1999-4915\/14\/9\/1920","DOI":"10.3390\/v14091920"},{"key":"60696_CR25","doi-asserted-by":"crossref","unstructured":"Abir, A. S. M. et al. Immunogenicity of Matrix Protein 2 Ectodomain (M2e) Displayed on Nodavirus-like Particles as Avian Influenza Vaccine for Poultry, Vaccines, vol. 13, no. 7, p. 701, [Online]. (2025). Available: https:\/\/www.mdpi.com\/2076-393X\/13\/7\/701","DOI":"10.3390\/vaccines13070701"},{"key":"60696_CR26","doi-asserted-by":"publisher","unstructured":"Krammer, F. et al. NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines? mBio, vol. 9, no. 2, pp. (2018). https:\/\/doi.org\/10.1128\/mbio.02332-17, doi: 10.1128\/mbio.02332-17.","DOI":"10.1128\/mbio.02332-17"},{"key":"60696_CR27","doi-asserted-by":"publisher","unstructured":"Eichelberger, M. C. & Monto, A. S. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection, J Infect Dis, vol. 219, no. Suppl_1, pp. S75-s80, Apr 8 (2019). https:\/\/doi.org\/10.1093\/infdis\/jiz017","DOI":"10.1093\/infdis\/jiz017"},{"key":"60696_CR28","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s, G. et al. Boosting neuraminidase immunity in the presence of hemagglutinin with the next generation of influenza vaccines, npj Vaccines, vol. 9, no. 1, p. 228, 2024\/11\/19 2024. https:\/\/doi.org\/10.1038\/s41541-024-01011-x","DOI":"10.1038\/s41541-024-01011-x"},{"key":"60696_CR29","doi-asserted-by":"publisher","unstructured":"Zhang, X. & Ross, T. M. Anti-neuraminidase immunity in the combat against influenza. Expert Rev. Vaccines, 23, 1, pp. 474\u2013484, 2024\/12\/31 2024, https:\/\/doi.org\/10.1080\/14760584.2024.2343689","DOI":"10.1080\/14760584.2024.2343689"},{"key":"60696_CR30","doi-asserted-by":"publisher","unstructured":"Eichelberger, M. C., Morens, D. M. & Taubenberger, J. K. Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness. Current Opin. Immunology, 53, pp. 38\u201344, 2018\/08\/01\/ 2018, doi: https:\/\/doi.org\/10.1016\/j.coi.2018.03.025","DOI":"10.1016\/j.coi.2018.03.025"},{"key":"60696_CR31","doi-asserted-by":"publisher","unstructured":"Alnajran, H. et al. Design of a peptide-based vaccine against human respiratory syncytial virus using a reverse vaccinology approach: evaluation of immunogenicity, antigenicity, allergenicity, and toxicity, Frontiers in Immunology, Original Research vol. Volume 16\u20132025, 2025-March-28 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1546254","DOI":"10.3389\/fimmu.2025.1546254"},{"key":"60696_CR32","doi-asserted-by":"publisher","unstructured":"Zhu, H., Li, X., Ren, X., Chen, H. & Qian, P. Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA,Vaccine, vol. 40, no. 44, pp. 6352\u20136361, Oct 19 2022. https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.058","DOI":"10.1016\/j.vaccine.2022.09.058"},{"key":"60696_CR33","doi-asserted-by":"publisher","unstructured":"Proudfoot, O. et al. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung. BMC Infect. Dis. 15, 101. https:\/\/doi.org\/10.1186\/s12879-015-0838-7 (Feb 26 2015).","DOI":"10.1186\/s12879-015-0838-7"},{"key":"60696_CR34","doi-asserted-by":"publisher","unstructured":"Roque, J. A. 3 et al. Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan. Int. J. Pharm. 656, 124076. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124076 (May 10 2024).","DOI":"10.1016\/j.ijpharm.2024.124076"},{"issue":"8016","key":"60696_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630(8016), 493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w (2024).","journal-title":"Nature"},{"issue":"2","key":"60696_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4149\/av_2018_203","volume":"62","author":"ME Hamad","year":"2018","unstructured":"Hamad, M. E., Amer, H. M., Farrag, M. A., Osman, A. H. & Almajhdi, F. N. Naked DNA immunization with full-length attachment gene of human respiratory syncytial virus induces safe and protective immune response. Acta Virol. 62 (2), 137\u2013146. https:\/\/doi.org\/10.4149\/av_2018_203 (2018).","journal-title":"Acta Virol."},{"key":"60696_CR37","doi-asserted-by":"publisher","unstructured":"Zasztowt-Sternicka, M. et al. Immunogenicity of inactivated quadrivalent influenza vaccine in pregnant women, including the level of postvaccination antibodies in umbilical cord blood, Vaccine, vol. 53, p. 127047, 2025\/04\/19\/ 2025. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127047","DOI":"10.1016\/j.vaccine.2025.127047"},{"key":"60696_CR38","doi-asserted-by":"publisher","unstructured":"Myburgh, L. et al. Guided design for the development of an evolution-proof influenza vaccine, Vaccine, vol. 59, p. 127281, 2025\/06\/20\/ 2025. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127281","DOI":"10.1016\/j.vaccine.2025.127281"},{"key":"60696_CR39","doi-asserted-by":"publisher","unstructured":"Lim, C. M. L., Komarasamy, T. V., Adnan, N., Radhakrishnan, A. K. & Balasubramaniam, V. Recent Advances, Approaches and Challenges in the Development of Universal Influenza Vaccines. Influenza Other Respir Viruses. 18 (3), e13276. https:\/\/doi.org\/10.1111\/irv.13276 (Mar 2024).","DOI":"10.1111\/irv.13276"},{"key":"60696_CR40","doi-asserted-by":"crossref","unstructured":"Chai, S., Ye, C., Fan, C. & Jiang, H. Brief Comparison of Novel Influenza Vaccine Design Strategies, Vaccines, vol. 13, no. 11, p. 116410.3390\/vaccines13111164","DOI":"10.3390\/vaccines13111164"},{"key":"60696_CR41","doi-asserted-by":"publisher","unstructured":"Bullard, B. L. et al. An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets. NPJ Vaccines (1), 65. https:\/\/doi.org\/10.1038\/s41541-022-00492-y (2022).","DOI":"10.1038\/s41541-022-00492-y"},{"key":"60696_CR42","doi-asserted-by":"publisher","unstructured":"Tombari, W. et al. A novel mRNA-based multi-epitope vaccine for rabies virus computationally designed via reverse vaccinology and immunoinformatics, Scientific Reports, vol. 15, no. 1, p. 30355, 2025\/08\/19 https:\/\/doi.org\/10.1038\/s41598-025-16143-w (2025).","DOI":"10.1038\/s41598-025-16143-w"},{"key":"60696_CR43","doi-asserted-by":"crossref","unstructured":"Li, J., Ju, Y., Jiang, M., Li, S. & Yang, X. Y. Epitope-Based Vaccines: The Next Generation of Promising Vaccines Against Bacterial Infection, Vaccines, vol. 13, no. 3, p. 24810.3390\/vaccines13030248","DOI":"10.3390\/vaccines13030248"},{"issue":"1","key":"60696_CR44","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1038\/s41598-024-55372-3","volume":"14","author":"P Chao","year":"2024","unstructured":"Chao, P. et al. Proteomics-based vaccine targets annotation and design of multi-epitope vaccine against antibiotic-resistant Streptococcus gallolyticus. Sci. Rep. 14 (1), 4836. https:\/\/doi.org\/10.1038\/s41598-024-55372-3 (2024). \/02\/28 2024.","journal-title":"Sci. Rep."},{"key":"60696_CR45","doi-asserted-by":"publisher","unstructured":"Sharma, S. et al. Immunoinformatics approach for a novel multi-epitope subunit vaccine design against various subtypes of influenza A virus. Immunobiology 226 (2), 152053. https:\/\/doi.org\/10.1016\/j.imbio.2021.152053 (2021).","DOI":"10.1016\/j.imbio.2021.152053"},{"issue":"1","key":"60696_CR46","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12879-025-11066-3","volume":"25","author":"S Mohammadipour","year":"2025","unstructured":"Mohammadipour, S., Tavakkoli, H., Fatemi, S. N., Sharifi, A. & Mahmoudi, P. Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach. BMC Infect. Dis. 25(1), 688. https:\/\/doi.org\/10.1186\/s12879-025-11066-3 (2025).","journal-title":"BMC Infect. Dis."},{"key":"60696_CR47","doi-asserted-by":"publisher","unstructured":"Momajadi, L., Khanahmad, H. & Mahnam, K. Designing a multi-epitope influenza vaccine: an immunoinformatics approach. Sci. Rep. 14 (1), 25382. https:\/\/doi.org\/10.1038\/s41598-024-74438-w (Oct 25 2024).","DOI":"10.1038\/s41598-024-74438-w"},{"issue":"16","key":"60696_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169089","volume":"23","author":"M Scarcella","year":"2022","unstructured":"Scarcella, M. et al. The key role of lysosomal protease cathepsins in viral infections. Int. J. Mol. Sci. 23(16), 9089. https:\/\/doi.org\/10.3390\/ijms23169089 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 14","key":"60696_CR49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12859-022-04581-6","volume":"22","author":"A Maleki","year":"2022","unstructured":"Maleki, A., Russo, G., Parasiliti Palumbo, G. A. & Pappalardo, F. In silico design of recombinant multi-epitope vaccine against influenza A virus. BMC Bioinformatics 22(Suppl 14), 617. https:\/\/doi.org\/10.1186\/s12859-022-04581-6 (2022).","journal-title":"BMC Bioinformatics"},{"key":"60696_CR50","doi-asserted-by":"publisher","unstructured":"Mirzaee, M., Hosseini, S. M., Farahmand, B., Fotouhi, F. & Bahramali, G. A novel multi-epitope-based peptide recombinant influenza A vaccine prototype utilizing neuraminidase and hemagglutinin surface proteins: From in silico to preliminary study. Comput. Biol. Chem. 117, 108411. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108411 (Aug 2025).","DOI":"10.1016\/j.compbiolchem.2025.108411"},{"key":"60696_CR51","doi-asserted-by":"publisher","unstructured":"Samad, A., Meghla, N. S., Nain, Z., Karpi\u0144ski, T. M. & Rahman, M. S. Immune epitopes identification and designing of a multi-epitope vaccine against bovine leukemia virus: a molecular dynamics and immune simulation approaches. Cancer Immunol. Immunother. 71 (10), 2535\u20132548. https:\/\/doi.org\/10.1007\/s00262-022-03181-w (Oct 2022).","DOI":"10.1007\/s00262-022-03181-w"},{"key":"60696_CR52","doi-asserted-by":"publisher","unstructured":"Jiang, P. et al. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model, Vaccine, vol. 35, no. 23, pp. 3096\u20133103, May 25 https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.031 (2017).","DOI":"10.1016\/j.vaccine.2017.04.031"},{"key":"60696_CR53","doi-asserted-by":"publisher","unstructured":"Kar, T. et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci. Rep. 10 (1), 10895. https:\/\/doi.org\/10.1038\/s41598-020-67749-1 (Jul 2 2020).","DOI":"10.1038\/s41598-020-67749-1"},{"key":"60696_CR54","doi-asserted-by":"publisher","unstructured":"Deng, Y. et al. Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses, Elife, vol. 14, Nov 13 https:\/\/doi.org\/10.7554\/eLife.107042 (2025).","DOI":"10.7554\/eLife.107042"},{"key":"60696_CR55","doi-asserted-by":"crossref","unstructured":"Memoli, M. J. et al. Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A\/H1N1 Virus Healthy Human Challenge Model, mBio, vol. 7, no. 2, pp. e00417-16, Apr 19 2016, doi: 10.1128\/mBio. 00417\u2009\u2013\u200916.","DOI":"10.1128\/mBio.00417-16"},{"key":"60696_CR56","doi-asserted-by":"publisher","unstructured":"Lim, W. W., Feng, S., Wong, S. S., Sullivan, S. G. & Cowling, B. J. Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine Efficacy Against Symptomatic Influenza A(H1N1), A(H3N2), and B\/Victoria Virus Infections. J Infect. Dis, 230, 1, pp. 152\u2013160, Jul 25 https:\/\/doi.org\/10.1093\/infdis\/jiae122 (2024).","DOI":"10.1093\/infdis\/jiae122"},{"key":"60696_CR57","doi-asserted-by":"crossref","unstructured":"Jang, Y. H. & Seong, B. L. Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses, Vaccines, vol. 9, no. 4, p. 353, [Online].Available: https:\/\/www.mdpi.com\/2076-393X\/9\/4\/353 (2021).","DOI":"10.3390\/vaccines9040353"},{"issue":"3","key":"60696_CR58","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e19","volume":"24","author":"SH Kim","year":"2024","unstructured":"Kim, S. H. et al. Influenza virus-derived CD8 T cell epitopes: Implications for the development of universal influenza vaccines. Immune Netw. 24(3), e19. https:\/\/doi.org\/10.4110\/in.2024.24.e19 (2024).","journal-title":"Immune Netw."},{"key":"60696_CR59","doi-asserted-by":"publisher","unstructured":"Zheng, Y. et al. Influenza A virus dissemination and infection leads to tissue resident cell injury and dysfunction in viral sepsis, eBioMedicine, vol. 116, p. 105738, 2025\/06\/01\/ 2025. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105738","DOI":"10.1016\/j.ebiom.2025.105738"},{"issue":"6775","key":"60696_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr4635","volume":"390","author":"H Ichise","year":"2025","unstructured":"Ichise, H. et al. Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection. Science 390(6775), eadr4635. https:\/\/doi.org\/10.1126\/science.adr4635 (2025).","journal-title":"Science"},{"key":"60696_CR61","doi-asserted-by":"publisher","unstructured":"Adelusi, T. I. et al. Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic, Scientific Reports, vol. 15, no. 1, p. 2563, 2025\/01\/20 https:\/\/doi.org\/10.1038\/s41598-024-72495-9 (2025).","DOI":"10.1038\/s41598-024-72495-9"},{"key":"60696_CR62","doi-asserted-by":"publisher","unstructured":"Fatahi, G. et al. Designing of an efficient DC-inducing multi-epitope vaccine against Epstein Barr virus targeting the GP350 using immunoinformatics and molecular dynamic simulation. Biochemistry Biophys. Reports, 42, p. 101966, 2025\/06\/01 https:\/\/doi.org\/10.1016\/j.bbrep.2025.101966 (2025).","DOI":"10.1016\/j.bbrep.2025.101966"},{"key":"60696_CR63","doi-asserted-by":"crossref","unstructured":"Mokalla, V. R., Gundarapu, S., Kaushik, R. S., Rajput, M. & Tummala, H. Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy, Vaccines, vol. 13, no. 9, p. 96210.3390\/vaccines13090962.","DOI":"10.3390\/vaccines13090962"},{"key":"60696_CR64","doi-asserted-by":"publisher","unstructured":"Yuan, L. et al. A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice, eBioMedicine, vol. 106, p. 105269, 2024\/08\/01 https:\/\/doi.org\/10.1016\/j.ebiom.2024.105269 ( 2024).","DOI":"10.1016\/j.ebiom.2024.105269"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60696-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:02:21Z","timestamp":1790946141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60696-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60696"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60696-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Institutional Review Board (IRB) committee at King Fahad Medical City (KFMC), IRB log number 22\u2013156, and the King Saud University Institutional Ethical Committee reference number KSU-SE-23-95.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The graphical abstract was conceptualized by Dr. Bandar Alosaimi. Generative artificial intelligence (ChatGPT, OpenAI) was used to support visualization during preparation of the graphical abstract. All content was reviewed, verified, and approved by the authors.","order":3,"name":"Ethics","label":"AI use disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30667"}}